|
[1]
|
中华医学会呼吸病学分会, 中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2024年版) [J]. 中华结核和呼吸杂志, 2024, 47(8): 716-729.
|
|
[2]
|
雷光焰, 张艰, 闫小龙. 肺结节诊治西北地区专家共识(2021年版) [J]. 中国医药科学, 2021, 11(23): 16-22+5.
|
|
[3]
|
Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., et al. (2024) Cancer Incidence and Mortality in China, 2022. Journal of the National Cancer Center, 4, 47-53. https://doi.org/10.1016/j.jncc.2024.01.006
|
|
[4]
|
Zeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J.S., Zou, X., et al. (2018) Changing Cancer Survival in China during 2003-15: A Pooled Analysis of 17 Population-Based Cancer Registries. The Lancet Global Health, 6, e555-e567. https://doi.org/10.1016/s2214-109x(18)30127-x
|
|
[5]
|
(2022) National Guidelines for Diagnosis and Treatment of Lung Cancer 2022 in China (English Version). Chinese Journal of Cancer Research, 34, 176-206. https://doi.org/10.21147/j.issn.1000-9604.2022.03.03
|
|
[6]
|
杨天舒, 赖宇鑫, 李梦乾, 等. 肺结节的中医药治疗研究述评[J]. 中华中医药杂志, 2025, 40(2): 479-485.
|
|
[7]
|
周仲瑛. “伏毒”新识[J]. 世界中医药, 2007(2): 73-75.
|
|
[8]
|
袁振华, 任献青, 丁樱, 等. 儿童过敏性紫癜性肾炎从“伏毒损络”论治探微[J]. 中国中医基础医学杂志, 2022, 28(9): 1524-1527.
|
|
[9]
|
史鑫鑫, 符德玉, 周训杰, 等. 内经“气脉常通”理论内涵探讨[J]. 时珍国医国药, 2023, 34(10): 2464-2466.
|
|
[10]
|
徐佳仪, 王真. 150例肺部小结节患者中医体质分布探析[J]. 浙江中西医结合杂志, 2018, 28(4): 330-333.
|
|
[11]
|
肖长斌, 陈凯丽, 黄思雨, 等. 基于“伏毒理论”探讨足细胞自噬在糖尿病肾病中的作用[J/OL]. 辽宁中医杂志: 1-17. https://link.cnki.net/urlid/21.1128.R.20251024.1700.046, 2026-07-09.
|
|
[12]
|
马啸, 任燕群, 杨默, 等. 基于国医大师韩明向教授治疗肺结节临证经验及用药举隅[J/OL]. 辽宁中医杂志: 1-5. https://link.cnki.net/urlid/21.1128.R.20250717.1007.022, 2026-07-09.
|
|
[13]
|
雷茂, 何佳玮, 马琼, 等. 肺结节“结癌转化”时空辨治体系的构建与应用[J]. 时珍国医国药, 2025, 36(15): 2916-2921.
|
|
[14]
|
Tu, X., An, B., Qi, H., Zhang, N. and Liu, Y. (2025) Traditional Chinese Medicine in the Prevention and Treatment of Lung Cancer Metastasis by Regulating Tumor-Associated Macrophages: A Narrative Review. Translational Lung Cancer Research, 14, 2281-2295. https://doi.org/10.21037/tlcr-2025-380
|
|
[15]
|
刘学春, 王光涛, 路志正. 国医大师路志正治疗肺结节病学术经验[J]. 中华中医药杂志, 2023, 38(6): 2629-2632.
|
|
[16]
|
贾国兵, 郭萄, 杨成军, 等. 从肺、脾、肾和水液代谢关系论肺结节的发生与辨治[J]. 中医杂志, 2022, 63(20): 1993-1996.
|
|
[17]
|
郝云, 赵一敏. 三焦膀胱水液代谢职司异同及临床意义探究[J]. 中国中医基础医学杂志, 2019, 25(8): 1038-1039.
|
|
[18]
|
王儒平, 陈雪梅. “脾为生痰之源, 肺为贮痰之器”的机理[J]. 河南中医, 2013, 33(9): 1396-1397.
|
|
[19]
|
郭天灏, 李柳, 程海波. 基于癌毒病机理论浅谈中医预防肿瘤研究进展[J]. 时珍国医国药, 2025, 36(12): 2332-2338.
|
|
[20]
|
Yanagawa, J., Tran, L.M., Salehi-Rad, R., Lim, R.J., Dumitras, C., Fung, E., et al. (2023) Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma. Cancer Research, 83, 3305-3319. https://doi.org/10.1158/0008-5472.can-23-0128
|
|
[21]
|
Zaiss, D.M.W., van Loosdregt, J., Gorlani, A., Bekker, C.P.J., Gröne, A., Sibilia, M., et al. (2013) Amphiregulin Enhances Regulatory T Cell-Suppressive Function via the Epidermal Growth Factor Receptor. Immunity, 38, 275-284. https://doi.org/10.1016/j.immuni.2012.09.023
|
|
[22]
|
易玲, 潘博, 唐蔚, 等. 国医大师潘敏求治疗肺结节经验[J]. 湖南中医杂志, 2022, 38(9): 45-48.
|
|
[23]
|
程钰, 胡凯文. 从气血津液角度探讨肺结节的中医防治手段[J]. 西部中医药, 2021, 34(9): 62-64.
|
|
[24]
|
王铭钧, 庞立健, 吕晓东, 等. 基于肺络理论论治肺结节病[J]. 世界中医药, 2022, 17(10): 1425-1429.
|
|
[25]
|
Del Valle, D.M., Kim-Schulze, S., Huang, H., Beckmann, N.D., Nirenberg, S., Wang, B., et al. (2020) An Inflammatory Cytokine Signature Predicts COVID-19 Severity and Survival. Nature Medicine, 26, 1636-1643. https://doi.org/10.1038/s41591-020-1051-9
|
|
[26]
|
Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D.L., Van Tassell, B.W., et al. (2021) Endothelial Dysfunction and Immunothrombosis as Key Pathogenic Mechanisms in COVID-19. Nature Reviews Immunology, 21, 319-329. https://doi.org/10.1038/s41577-021-00536-9
|
|
[27]
|
Hu, Z., Sui, Q., Jin, X., Shan, G., Huang, Y., Yi, Y., et al. (2024) IL6-STAT3-C/EBPβ-IL6 Positive Feedback Loop in Tumor-Associated Macrophages Promotes the EMT and Metastasis of Lung Adenocarcinoma. Journal of Experimental & Clinical Cancer Research, 43, Article No. 63. https://doi.org/10.1186/s13046-024-02989-x
|
|
[28]
|
Wu, J., He, Z., Zhuang, W., Xia, X., Li, Z., Mo, A., et al. (2025) Mechanisms of Inflammation-Driven Lung Cancer: From External Influences to Internal Regulation. Clinical Immunology, 279, Article 110572. https://doi.org/10.1016/j.clim.2025.110572
|
|
[29]
|
王蓝康, 迟文成, 蒋巍, 等. 基于“正虚伏毒”理论浅析肿瘤微环境辨治[J]. 现代中西医结合杂志, 2025, 34(3): 392-396.
|
|
[30]
|
孙睿博, 韩钦芮, 徐萌, 等. 肿瘤转移前龛环境的正虚痰瘀病机探讨[J]. 中华中医药杂志, 2021, 36(6): 3529-3532.
|
|
[31]
|
胡家蕊, 张晓梅, 李梦乾, 等. 姜良铎从通从毒论治肺结节[J]. 中医杂志, 2021, 62(22): 1956-1959.
|
|
[32]
|
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., et al. (2021) Inflammation and Tumor Progression: Signaling Pathways and Targeted Intervention. Signal Transduction and Targeted Therapy, 6, Article No. 263. https://doi.org/10.1038/s41392-021-00658-5
|
|
[33]
|
Aktay-Cetin, Ö., Pullamsetti, S.S., Herold, S. and Savai, R. (2025) Lung Tumor Immunity: Redirecting Macrophages through Infection-Induced Inflammation. Trends in Immunology, 46, 471-484. https://doi.org/10.1016/j.it.2025.04.004
|
|
[34]
|
Rooney, C. and Sethi, T. (2011) The Epithelial Cell and Lung Cancer: The Link between Chronic Obstructive Pulmonary Disease and Lung Cancer. Respiration, 81, 89-104. https://doi.org/10.1159/000323946
|
|
[35]
|
Rastogi, S., Aldosary, S., Saeedan, A.S., Ansari, M.N., Singh, M. and Kaithwas, G. (2023) NF-κB Mediated Regulation of Tumor Cell Proliferation in Hypoxic Microenvironment. Frontiers in Pharmacology, 14, Article ID: 1108915. https://doi.org/10.3389/fphar.2023.1108915
|
|
[36]
|
张悦, 王雪慧, 陈叶, 等. 基于“脾为五脏之使”探讨肺结节“结-癌”转化及防治思路[J]. 中国医药导报, 2024, 21(33): 175-179.
|
|
[37]
|
杨天舒, 张永生, 柴欣楼, 等. 基于“形神一体观”探讨肺结节并发肺外结节病机及治疗[J]. 北京中医药大学学报, 2023, 46(10): 1345-1349.
|
|
[38]
|
陈敏, 刘文平, 余阳, 等. 张之文“调气津、开玄府、透窠囊、防癌毒”治疗肺结节经验[J]. 中医杂志, 2024, 65(14): 1428-1433.
|
|
[39]
|
李传慧, 刘骅漫, 贾新华. 从瘀毒角度运用治未病思想防治肺结节[J]. 新中医, 2023, 55(12): 185-189.
|
|
[40]
|
张传龙, 姜晓晨, 庞博, 等. 基于“热极成毒”理论探讨肺“炎-癌转化”与防治思路[J]. 北京中医药大学学报, 2022, 45(3): 291-295.
|
|
[41]
|
骆亚莉, 周啸天, 魏本君, 等. 中医学对炎性微环境与炎症恶性转化的认识[J]. 时珍国医国药, 2022, 33(8): 1966-1968.
|
|
[42]
|
Khandia, R. and Munjal, A. (2020) Interplay between Inflammation and Cancer. Advances in Protein Chemistry and Structural Biology, 119, 199-245.
|
|
[43]
|
Wang, Y., An, J., Zhou, J., Chang, L., Zhang, Q. and Peng, F. (2025) Hydroxysafflor Yellow A: A Natural Pigment with Potential Anticancer Therapeutic Effect. Frontiers in Pharmacology, 15, Article ID: 1495393. https://doi.org/10.3389/fphar.2024.1495393
|
|
[44]
|
Lee, S., Cho, S., Li, Y., Bae, C., Park, K.M. and Park, D. (2020) Anti-Inflammatory Effect of Curcuma longa and Allium hookeri Co-Treatment via NF-κB and COX-2 Pathways. Scientific Reports, 10, Article No. 5718. https://doi.org/10.1038/s41598-020-62749-7
|
|
[45]
|
王含雪, 邢淑雁, 杨佳, 等. 浙贝母提取物协同急性炎症刺激干预非小细胞肺癌的作用探讨[J]. 中国免疫学杂志, 2025, 41(8): 1800-1805.
|
|
[46]
|
刘艺, 张楚楚, 尹炳驿, 等. 基于“因加而发”探讨肺结节“结癌转化”的防治[J]. 中医杂志, 2024, 65(1): 39-43.
|
|
[47]
|
李晨, 魏小曼, 闫秋莹, 等. 基于肺癌治疗探讨化痰解毒方药的临床应用[J/OL]. 中国实验方剂学杂志: 1-17. https://www.chndoi.org/Resolution/Handler?doi=10.13422/j.cnki.syfjx.20252221, 2026-07-09.
|
|
[48]
|
Teng, J., Mei, Q., Zhou, X., Tang, Y., Xiong, R., Qiu, W., et al. (2020) Polyphyllin VI Induces Caspase-1-Mediated Pyroptosis via the Induction of ROS/NF-κB/NLRP3/GSDMD Signal Axis in Non-Small Cell Lung Cancer. Cancers, 12, Article 193. https://doi.org/10.3390/cancers12010193
|
|
[49]
|
冯佳, 袁傲, 黄芳, 等. 半枝莲含药血清通过抑制mTOR信号通路影响非小细胞肺癌NCI-H1650细胞上皮间质转化[J]. 中华中医药学刊, 2023, 41(6): 60-64.
|
|
[50]
|
胡佳奇, 许博文, 程孟祺, 等. “石见穿-猫爪草”药对治疗肺癌作用机制探讨[J]. 海南医学院学报, 2022, 28(11): 860-869.
|
|
[51]
|
褚文丰, 张念志. 张念志教授基于“气瘀痰虚”理论辨证论治肺结节临证经验[J]. 中国医药导报, 2024, 21(29): 149-152.
|
|
[52]
|
韩宁, 李秋实, 王鑫洋, 等. 人参皂苷Rg3抑制肺癌细胞增殖和侵袭的作用及机制[J]. 中国临床药理学杂志, 2023, 39(20): 2942-2945.
|
|
[53]
|
Mohanan, P., Subramaniyam, S., Mathiyalagan, R. and Yang, D. (2018) Molecular Signaling of Ginsenosides Rb1, Rg1, and Rg3 and Their Mode of Actions. Journal of Ginseng Research, 42, 123-132. https://doi.org/10.1016/j.jgr.2017.01.008
|
|
[54]
|
刘兆华, 王彦君, 申明, 等. 黄芪多糖对肺肿瘤转移前微环境中HIF-1和S100A8/A9蛋白表达及肺转移的影响[J]. 中国实验动物学报, 2023, 31(7): 871-879.
|
|
[55]
|
马龙, 王至婉, 春柳, 等. 肺结节“辨病-辨证-辨体”的证候诊断模式探析[J]. 中华中医药学刊, 2023, 41(5): 194-196.
|